Drag a card by its title · ⚙ to size, swap or remove

The company

Cardio Diagnostics Holdings Inc.

CDIO · Nasdaq

Health CareDiagnostics & LabsNot moving yet

CDIO stood above a rising 150-day average in 0 of the last 52 weekly readings. It is 10.8% below that average now. Diagnostics & Labs: 48% of its 44 stocks in an uptrend (−2 points in four weeks); Health Care: 25% (−11 points in four weeks).

SEC filings

Statistics

Rotation: Not moving yet
Weeks in an uptrend: out for 52
Industry in uptrend: 48% -2 in 4 wk
Insider buys, 12 months: $0
Insider sales, 12 months: $0
Officials’ trades on record: 0
Institutions holding: 17 (+2)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 0 of 52 weeks.

17 Apr – 16 Oct

Diagnostics & Labs: About half its stocks are in an uptrend and the share has held steady. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0

Sale orders, 12 months0

Buyers · sellers0 · 0

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders17+2 on the quarter

New · exited4 · 2

Reported value$423K

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change
RENAISSANCE TECHNOLOGIES LLCadded · filed 13 Aug 2026	49,200$108K	+33,852+220.6%
BlackRock, Inc.unchanged · filed 7 Aug 2026	34,708$76K	00.0%
GEODE CAPITAL MANAGEMENT, LLCreduced · filed 12 Aug 2026	26,233$57K	-5,944−18.5%
VANGUARD CAPITAL MANAGEMENT LLCunchanged · filed 13 Aug 2026	20,155$44K	00.0%
CITADEL ADVISORS LLCnew · filed 14 Aug 2026	19,071$42K	+19,071
XTX Topco Ltdnew · filed 14 Aug 2026	16,093$35K	+16,093
JANE STREET GROUP, LLCreduced · filed 14 Aug 2026	11,933$26K	-69,350−85.3%
STATE STREET CORPnew · filed 7 Aug 2026	10,099$22K	+10,099
VANGUARD FIDUCIARY TRUST COreduced · filed 13 Aug 2026	2,824$6,185	-1,145−28.8%
Tower Research Capital LLC (TRC)reduced · filed 11 Aug 2026	1,809$3,962	-383−17.5%

30 Jun 2025 – 30 Jun 2026

News

No headline names it lately.

Everyone who traded it

James Intrater Director · last 30 Sep 20260 · 0

Paul Frederick Burton Director · last 30 Sep 20260 · 0

Peter K. Fung Director · last 30 Sep 20260 · 0

Wendy J. Betts Director · last 30 Sep 20260 · 0

Oded Levy Director · last 30 Sep 20240 · 0

Stanley K. Lau Director · last 30 Sep 20240 · 0

Meeshanthini Dogan Chief Executive Officer · last 6 Sep 20246 · 0

Robert Philibert Chief Medical Officer · last 6 Sep 20243 · 0

Timur Dogan Chief Technology Officer · last 6 Sep 20244 · 0

Elisa Luqman V Chief Financial Officer · last 23 Jan 20240 · 0

Khullani Abdullahi VP of Revenue and Strategy · last 23 Jan 20240 · 0

Warren Hosseinion Director · last 23 Jan 20240 · 0

Same industry

TRIB Trinity BiotechLeading+97%

CDNA CareDxLeading+83%

XGN ExagenLeading+49%

NTRA NateraLeading+46%

FTRE Fortrea HoldingsLeading+41%

PSNL PersonalisLeading+35%

TKNO Alpha TeknovaLeading+32%

ADPT Adaptive BiotechnologiesLeading+20%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Return on capital employedFY 2025 · to 31 Dec 2025-90.5%

Share count trendFY 2025 · to 13 Mar 202662.1%

Cash and equivalentsFY 2025 · to 31 Dec 2025$0

Free cash flowFY 2025 · to 31 Dec 2025−$5.9M

Analyst forecasts

No analyst forecasts yet.